WO2013038861A1 - 液状化粧料 - Google Patents
液状化粧料 Download PDFInfo
- Publication number
- WO2013038861A1 WO2013038861A1 PCT/JP2012/070673 JP2012070673W WO2013038861A1 WO 2013038861 A1 WO2013038861 A1 WO 2013038861A1 JP 2012070673 W JP2012070673 W JP 2012070673W WO 2013038861 A1 WO2013038861 A1 WO 2013038861A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- mass
- acid
- transparent
- cosmetic material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Definitions
- the present invention relates to a transparent to translucent liquid cosmetic. More specifically, the present invention relates to a liquid cosmetic that has a soft feel without stickiness and is excellent in stability under severe conditions such as freezing and high temperature.
- cosmetics formulated with finely divided oils have the advantage of being able to realize a wide range of use feelings and skin improvement effects according to tastes because they give skin-friendly feel and show high permeability to the skin. ing.
- cosmetics having such a configuration have problems in terms of stability over time and ease of production.
- Patent Document 1 discloses a liquid cosmetic material that is semitransparent to transparent in appearance with finely divided oil, and (a) an oil occupying 1.0 to 80.0% by weight of a branched saturated fatty acid that is liquid at room temperature. It describes that a lotion-like cosmetic having excellent long-term stability and vibration stability can be obtained by blending 0.01 to 3% by weight and (b) a hydrophilic surfactant.
- Patent Document 2 (a) 0.01 to 2% by mass of an oil component in which isostearic acid accounts for 34% by mass or more, (b) 0.04 to 1.0% by mass of a specific hydrophilic surfactant, and (C) A liquid cosmetic material that is white in appearance and contains a specific lipophilic surfactant in an amount of 0.001 to 0.75% by mass and suppresses the amount of the surfactant while maintaining the white turbidity. It has a refreshing feel and is excellent in long-term stability and vibration stability.
- Patent Document 3 discloses a skin external preparation in which an oily component is finely emulsified: (a) a higher alcohol and / or higher fatty acid that is liquid at normal temperature, (b) a nonionic hydrophilic surfactant, and (c) a water-soluble agent.
- a topical skin preparation obtained by mixing a dihydric alcohol and (d) water to form a lamellar liquid crystal phase and diluting it with an aqueous solvent is described.
- the component (a) accounts for 50% by weight or more of the lipid droplets, and it is considered to be a cloudy system due to its particle size, but it is characterized by easy manufacturing method, long-term stability and non-sticky usability. Have.
- the present invention provides a liquid makeup that is transparent and translucent and has a soft feeling without being sticky and having a stable transparency (L value) even under severe conditions such as freezing and high-temperature storage.
- the purpose is to provide a fee.
- the present inventors have conducted intensive studies, and as a result, blended isostearyl alcohol so as to occupy 60% by mass or more of oil, and combined with a specific hydrophilic surfactant, The present inventors have found that a liquid cosmetic material that exhibits excellent stability even under mild conditions and has a soft feeling of use can be obtained, thereby completing the present invention.
- the present invention contains (a) 0.01 to 3% by mass of oil and (b) a hydrophilic surfactant selected from polyoxyethylene hydrogenated castor oil and polyoxyethylene phytosterol, and has an L value.
- the cosmetics of the present invention have the advantages of liquid cosmetics formulated with finely divided oils, that is, the benefits of realizing a wide range of use feeling and skin improvement effects according to taste, as well as freezing and high temperature, etc. Even under the harshest conditions, stability is maintained, and a soft feeling can be obtained without stickiness.
- the cosmetic of the present invention is a liquid cosmetic containing finely divided oil in an aqueous medium. More specifically, the cosmetic is a transparent or translucent liquid cosmetic using skin lotion as a representative example.
- Toner lotion generally refers to a water-insoluble substance that is solubilized and thermodynamically stabilized to have a transparent liquid appearance, but the liquid cosmetic in the present invention is not limited to the above-described transparent solubilized type. Contains a transparent to translucent lotion using emulsion and lipid nanosphere technology, or a lotion type transparent to translucent essence.
- “transparent to translucent” means that the L value is 60 or more.
- the L value means a value of L in the Lab color system, and is a value that can be measured using a known color difference meter such as Color-EYE7000 (manufactured by GretagMacbeth) or a known spectrophotometer.
- the particle size of the oil fine particles dispersed in the aqueous medium is not particularly limited as long as the cosmetic has a transparent to translucent appearance, but it is usually preferable to have an average particle size of about 100 nm or less.
- the cosmetic of the present invention contains (a) an oil component and (b) a hydrophilic surfactant as essential components.
- Isostearyl alcohol accounts for 60 mass% or more of the (a) oil in the cosmetic of the present invention. When the proportion of isostearyl alcohol is less than 60% by mass, the usability is not soft, and the stability at freezing or at high temperature is also lowered.
- the oil other than isostearyl alcohol used in the present invention can be selected from oils conventionally used in cosmetics and the like, and is not particularly limited. Examples thereof include oils and fats, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, ester oils, silicone oils, and oil-soluble drugs.
- avocado oil camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanca oil, castor oil, flaxseed oil, Safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagari oil, Japanese kiri oil, jojoba oil, germ oil, triisooctanoic acid glycerin, triisopalmitic acid glycerin, iso Octyl palmitate, isopropyl isostearate, isostearyl isostearate, isocetyl isostearate, hexyl isostearate, myristyl isostearate, isocetyl octanoate, cetyl isooctanoate, isostearyl octan
- the blending amount of each of the various oils as described above, for example, higher fatty acids such as isostearic acid, is at most 40% by mass, for example, less than 30% by mass, or less than 20% by mass, or less than 10% by mass, or It becomes less than 1 mass%.
- the amount of oil in the cosmetic of the present invention is 0.01 to 3% by mass, preferably 0.1 to 1% by mass, more preferably 0.2 to 0.8% by mass.
- the oil content is less than 0.01% by mass, the predetermined effect cannot be obtained.
- the oil content exceeds 3% by mass, the surfactant for emulsifying the oil tends to increase, resulting in a sticky feeling. .
- the hydrophilic surfactant (b) in the cosmetic of the present invention is one or a mixture of two selected from polyoxyethylene hydrogenated castor oil and polyoxyethylene phytosterol.
- Polyoxyethylene hydrogenated castor oil is a hardened castor oil derivative having 20 to 100 ethylene oxide units, such as POE (40) hydrogenated castor oil, POE (60) hydrogenated castor oil, POE (100) hydrogenated castor oil, etc. Is mentioned.
- Commercial products such as Nikkor HCO (Nikko Chemicals), EMALEX HC (Nihon Emulsion), and UNIOX HC (Nippon Oil) may be used.
- Polyoxyethylene phytosterol is a phytosterol derivative having 10 to 50 ethylene oxide units, and examples thereof include POE (10) phytosterol, POE (20) phytosterol, and POE (30) phytosterol. Commercial products such as Nikkor BPS (Nikko Chemicals) can also be used.
- the blending amount of the (b) hydrophilic surfactant in the cosmetic of the present invention is preferably 0.01 to 3% by mass, more preferably 0.05 to 1% by mass, and still more preferably 0.1 to 0.2%. % By mass. If it is less than 0.01% by mass, stable emulsification becomes difficult, and if it exceeds 3% by mass, stickiness may occur.
- the cosmetic of the present invention preferably further contains (c) a lipophilic surfactant.
- a lipophilic surfactant By blending a lipophilic surfactant, stability during high temperature storage is further improved.
- the (c) lipophilic surfactant in the present invention is one or a mixture of two or more selected from polyglyceryl diisostearate, sorbitan sesquiisostearate, and sorbitan sesquioleate.
- Polyglyceryl diisostearate includes diglyceryl diisostearate and triglyceryl diisostearate which act as lipophilic surfactants, such as WOGEL-18DV (Matsumoto Fine Chemical), Cosmol 42V (Nisshin Oillio), EMALEX DISG (Japan Emulsion) Commercial products such as Risolex PGIS (higher alcohol industry) can be used.
- sorbitan sesquiisostearate examples include Estemol 182V (Nisshin Oilio), EMALEX SPIS-150 (Nihon Emulsion), Nikkor SI-15RV (Nikko Chemicals), etc., and sorbitan sesquioleate, EMALEX SPO-150 (Nihon Emulsion)
- Commercial products such as Nikkor SO-15V (Nikko Chemicals), NOFABLE SO-852S (Nissho), and Cosmol 82 (Nisshin Oilio) are also preferably used.
- the blending amount of the (c) lipophilic surfactant in the cosmetic of the present invention is preferably 0.01 to 2% by mass, more preferably 0.01 to 1.5% by mass, and further preferably 0.05 to 1%. % By mass.
- the cosmetics of this invention can mix
- the (d) salt-type drug in the present invention means a water-soluble drug capable of forming a salt, and is not particularly limited as long as it is a water-soluble drug that can be usually blended in cosmetics and the like.
- Preferred examples include salts of L-ascorbic acid and its derivatives, salts of tranexamic acid and its derivatives, salts of alkoxysalicylic acid and its derivatives, salts of glutathione and its derivatives, etc., but are not limited to these examples.
- L-ascorbic acid is generally referred to as vitamin C, and has a strong reductive action, a cell respiration action, an enzyme activation action, a collagen formation action, and a melanin reduction action.
- L-ascorbic acid derivatives include L-ascorbic acid monoesters such as L-ascorbic acid monophosphate and L-ascorbic acid-2-sulfate; L-ascorbic acid triesters such as L-ascorbic acid triphosphate And L-ascorbic acid glucosides such as L-ascorbic acid 2-glucoside.
- L-ascorbic acid, L-ascorbic acid phosphate, L-ascorbic acid-2-sulfate, and L-ascorbic acid 2-glucoside are preferably used in the form of salts.
- tranexamic acid derivatives include dimers of tranexamic acid (for example, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), and esters of tranexamic acid and hydroxyquinone (for example, 4- (trans-aminomethylcyclohexanecarboxylic acid 4′-hydroxyphenyl ester, etc.), ester form of tranexamic acid and gentisic acid (for example, 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5-hydroxybenzoic acid ), Amides of tranexamic acid (eg, trans-4-aminomethylcyclohexanecarboxylic acid methylamide, trans-4- (p-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid, trans-4-guani Roh methylcyclohexane carboxylic acid, etc.) is preferably used in the form
- Alkoxysalicylic acid is one in which the hydrogen atom at the 3-position, 4-position or 5-position of salicylic acid is substituted with an alkoxy group, and the alkoxy group as the substituent is preferably a methoxy group, an ethoxy group or a propoxy group.
- compound names include 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, 5-methoxysalicylic acid , 5-ethoxysalicylic acid, 5-propoxysalicylic acid and the like.
- it uses suitably in the form of each salt of alkoxy salicylic acid and its derivatives (ester etc.).
- the salt of the drug is not particularly limited, and examples thereof include salts such as ammonium salts and amino acid salts in addition to alkali metal salts or alkaline earth metal salts such as sodium salts, potassium salts and calcium salts.
- salt-type drugs can be blended, and the blending amount is arbitrary. Usually, it is blended in the range of about 0.1 to 30.0% by mass with respect to the total amount of the liquid cosmetic.
- various components usually used in liquid cosmetics may be appropriately blended within a range that does not impair the effects of the present invention.
- Specific examples include glycols such as propylene glycol, dipropylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, diethylene glycol, triethylene glycol, and polyethylene glycol; glycerin such as glycerin, diglycerin, and polyglycerin.
- Sugar sugars such as sorbitol, mannitol, maltitol, xylitol, erythritol; sugars such as fructose, glucose, galactose, maltose, lactose, trehalose; inorganic powders such as talc, kaolin, mica, silica, zeolite; polyamide resin powder (Nylon powder), polyethylene powder, polymethyl methacrylate powder, polystyrene powder, copolymer resin powder of styrene and acrylic acid, organic powder such as cellulose powder; Inorganic white pigments such as titanium oxide and zinc oxide; inorganic red pigments such as iron oxide (Bengara); inorganic yellow pigments such as yellow iron oxide and ocher; black pigments such as black iron oxide and carbon black; chromium oxide; Inorganic green pigments such as chromium hydroxide and cobalt titanate; inorganic blue pigments such as ultramarine and bitumen; pearl pigment
- the transparent to translucent liquid cosmetic composition of the present invention can be used as a skin lotion, cosmetic liquid and the like for skin care, as well as a sunscreen base, a suntan base, and a cleaning base. Among these, it is particularly preferable to use as a lotion.
- the cosmetic of the present invention can be produced according to a method usually used for liquid cosmetics such as lotions. Specifically, by dissolving a water-soluble component in water to form an aqueous phase, mixing a water-insoluble component such as oil with an amphiphilic component (surfactant), adding it to the aqueous phase, and stirring. Prepared.
- the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.
- the blending amount means mass% unless otherwise specified.
- Liquid cosmetics skin lotions
- Tables 1 to 4 Liquid cosmetics (skin lotions) were prepared according to the formulations shown in Tables 1 to 4 below, and their properties were evaluated according to the following evaluation methods and evaluation criteria. The results are also shown in the table.
- "Usability evaluation method” Each sample of the examples and comparative examples was actually used by 10 professional panels and evaluated for usability (non-stickiness and softness). Each panel was subjected to a five-step sensory evaluation according to the following evaluation point criteria, and the total score was determined based on the following evaluation criteria.
- Evaluation criteria 5: Very good 4: Excellent 3: Normal 2: Inferior 1: Very inferior “Evaluation criteria” ⁇ : Total score of 40 points or more ⁇ : Total score of 30 to 39 points ⁇ : Total score of 20 to 29 points ⁇ : Total score of 19 points or less
- Stability evaluation method The stability of each sample was evaluated under the following conditions. -Stability of products stored at 60 ° C: Evaluation of L value fluctuation after storage at 60 ° C for 1 week. -Stability of products stored at 50 ° C: Evaluation of L value fluctuation after storage at 50 ° C for 2 months. ⁇ Stability after freezing and thawing: After freezing, thawing at room temperature and returning to room temperature, the change in L value was evaluated. "Evaluation criteria" ⁇ : L value fluctuation is less than ⁇ 3 ⁇ ⁇ : L value fluctuation is ⁇ 3 or more and less than ⁇ 4 ⁇ : L value fluctuation is ⁇ 4 or more and less than ⁇ 10 ⁇ : L value fluctuation is ⁇ 10 or more
- liquid cosmetics prepared by combining isostearyl alcohol so as to occupy 60% by mass or more of oil and combining with a specific hydrophilic surfactant (Examples) 1 to 11) have extremely good usability (non-stickiness, softness), and excellent stability even under severe conditions such as high-temperature storage at 50 ° C. or 60 ° C. or freezing / thawing. It was.
- Comparative Examples 1 to 6 and 8 which do not contain isostearyl alcohol or whose blending amount is less than 60% by mass of the oil component, particularly soft usability is not obtained and stability is remarkably inferior. It became.
- Comparative Example 7 in which the blending amount of the oil component exceeded 3% by mass produced stickiness and was inferior in usability.
- Liquid cosmetics were prepared according to the formulation shown in Table 5 below and formulated with a salt-type drug (4-methoxysalicylic acid potassium salt), and the same evaluation as described above was performed. The results are also shown in Table 5.
- Example 14 Translucent lotion blending component Blending amount (% by mass) Ethanol 5 Glycerin 5 Dipropylene glycol 7 Butylene glycol 5 Erythritol 1 Xylitol 1 PEG / PPG-17 / 4 dimethyl ether 3 POE (30) phytosterol 0.14 Sorbitan sesquioleate 0.02 Isostearyl alcohol 0.3 ⁇ -Olefin oligomer 0.2 Xanthan gum 0.1 Citric acid Appropriate amount Sodium citrate Appropriate amount Sodium metaphosphate Appropriate amount Phenoxyethanol Appropriate perfume Appropriate amount Ion-exchanged water Residue
- a water phase was prepared by sequentially dissolving water-soluble components in water according to a conventional method.
- the water-insoluble component was added to the aqueous phase after mixing with the amphiphilic component.
- Example 15 Translucent lotion blending component Blending amount (% by mass) Glycerin 10 Dipropylene glycol 7 Butylene glycol 5 POE (10) methyl glucoside 2 Erythritol 1 PEG-400 1 PEG / PPG-14 / 7 dimethyl ether 1 Polyoxyethylene hydrogenated castor oil (60EO) 0.16 Polyglyceryl-2 diisostearate 0.08 Isostearyl alcohol 0.3 Hydroxyethyl cellulose 0.1 Citric acid appropriate amount sodium citrate appropriate amount edetate disodium appropriate amount phenoxyethanol appropriate amount perfume appropriate amount ion-exchanged water remainder
- a water phase was prepared by sequentially dissolving water-soluble components in water according to a conventional method.
- the water-insoluble component was added to the aqueous phase after mixing with the amphiphilic component.
- Example 16 Translucent lotion blending component for whitening Blending amount (% by mass) Ethanol 7 Glycerin 4 Dipropylene glycol 5 Butylene glycol 3 POE (10) methyl glucoside 1 PEG-20 1 PEG / PPG-14 / 7 dimethyl ether 1 Polyoxyethylene hydrogenated castor oil (60EO) 0.16 Polyglyceryl-2 diisostearate 0.08 Isostearyl alcohol 0.18 Isostearic acid 0.06 ⁇ -Olefin oligomer 0.06 Dipotassium glycyrrhizinate 0.1 Tocopherol acetate 0.1 Tranexamic acid 2 Ogon Extract 0.1 Giant extract 0.1 Yukinoshita extract 0.1 Nettle extract 0.1 Citric acid appropriate amount sodium citrate appropriate amount edetate trisodium appropriate amount phenoxyethanol appropriate amount perfume appropriate amount ion-exchanged water remainder
- a water phase was prepared by sequentially dissolving water-soluble components in water according to a conventional method.
- the water-insoluble component was added to the aqueous phase after mixing with the amphiphilic component.
- Example 17 Translucent lotion blending component for whitening Blending amount (% by mass) Ethanol 8 Glycerin 3 Dipropylene glycol 5 Butylene glycol 3 POE (10) methyl glucoside 1 PEG-20 1 PEG / PPG-14 / 7 dimethyl ether 1 Polyoxyethylene hydrogenated castor oil (60EO) 0.16 Polyglyceryl-2 diisostearate 0.08 Isostearyl alcohol 0.18 Isostearic acid 0.06 ⁇ -Olefin oligomer 0.06 Dipotassium glycyrrhizinate 0.1 Ascorbic acid glucoside 2 Arginine hydrochloride 0.1 Potassium hydroxide 0.4 Ogon Extract 0.1 Giant extract 0.1 Yukinoshita extract 0.1 Nettle extract 0.1 Citric acid appropriate amount sodium citrate appropriate amount disodium edetate appropriate amount paraben appropriate amount perfume appropriate amount ion-exchange water remainder
- a water phase was prepared by sequentially dissolving water-soluble components in water according to a conventional method.
- the water-insoluble component was added to the aqueous phase after mixing with the amphiphilic component.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
水性媒体中に分散される油分微粒子の粒径は、化粧料が透明から半透明の外観を有する範囲であれば特に限定されないが、通常は約100nm以下の平均粒径とするのが好ましい。
具体例を挙げれば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリイソオクタン酸グリセリン、トリイソパルミチン酸グリセリン、イソパルミチン酸オクチル、イソステアリン酸イソプロピル、イソステアリン酸イソステアリル、イソステアリン酸イソセチル、イソステアリン酸ヘキシル、イソステアリン酸ミリスチル、オクタン酸イソセチル、イソオクタン酸セチル、オクタン酸イソステアリル、イソノナン酸イソデシル、ジメチルオクタン酸オクチルドデシル、ミリスチン酸オレイル、エルカ酸イソステアリル、ステアリン酸イソセチル、ステアリン酸オクチル、パルミチン酸イソステアリル、パルミチン酸イソセチル、パルミチン酸オクチル、ミリスチン酸イソステアリル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、ミリスチン酸デシル、パルミチン酸イソプロピル、ミリスチン酸イソプロピル、トリイソステアリン酸トリメチロールプロパン、ジカプリン酸ネオペンチルグリコール、セバシン酸ジオクチル、12-ステアロイルオキシステアリン酸オクチルドデシル、ステアロイルグルタミン酸ジオクチルドデシル、アジピン酸ジオクチル、リンゴ酸ジイソステアリル、メトキシケイ皮酸オクチル、乳酸オクチルドデシル、乳酸イソステアリル、パラジメチルアミノ安息香酸オクチル、流動パラフィン、スクワラン、イソパラフィン、α-オレフィンオリゴマー、ポリブテン、揮発性環状シリコーン、揮発性ジメチルポリシロキサン、メチルフェニルシリコーン、オレイルアルコール、2-オクチルドデカノール、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、コレステロール、フィトステロール、マイクロクリスタリンワックス、ベヘニルアルコール、ステアリルアルコール、セチルアルコール、ベヘニン酸、ステアリン酸、イソステアリン酸、オレイン酸、ミリスチン酸等である。これらは一種を単独でまたは二種以上を組み合わせて用いることができる。
ポリオキシエチレン硬化ヒマシ油は、20~100のエチレンオキサイド単位を持つ硬化ヒマシ油誘導体であり、例えば、POE(40)硬化ヒマシ油、POE(60)硬化ヒマシ油、POE(100)硬化ヒマシ油等が挙げられる。ニッコールHCO(日光ケミカルズ)、EMALEX HC(日本エマルジョン)、ユニオックスHC(日油)等の市販品を使用してもよい。
ポリオキシエチレンフィトステロールは、10~50のエチレンオキサイド単位を持つフィトステロール誘導体であり、例えばPOE(10)フィトステロール、POE(20)フィトステロール、POE(30)フィトステロール等が挙げられる。ニッコールBPS(日光ケミカルズ)等の市販品を使用することもできる。
本発明における(c)親油性界面活性剤は、ジイソステアリン酸ポリグリセリル、セスキイソステアリン酸ソルビタン、及びセスキオレイン酸ソルビタンから選択される1種又は2種以上の混合物である。
セスキイソステアリン酸ソルビタンとしては、エステモール182V(日清オイリオ)、EMALEX SPIS-150(日本エマルジョン)、ニッコール SI-15RV(日光ケミカルズ)等、セスキオレイン酸ソルビタンとしては、EMALEX SPO-150(日本エマルジョン)、ニッコール SO-15V(日光ケミカルズ)、NOFABLE SO-852S(日油)、コスモール82(日清オイリオ)等の市販品も好ましく使用される。
本発明における(d)塩型薬剤は、塩を形成可能な水溶性の薬剤を意味し、化粧料等に通常配合されうる水溶性薬剤であれば特に限定されない。L-アスコルビン酸およびその誘導体の塩、トラネキサム酸およびその誘導体の塩、アルコキシサリチル酸およびその誘導体の塩、グルタチオンおよびその誘導体の塩などが好ましい例として挙げられるが、これら例示に限定されるものでない。
本発明の化粧料は、化粧水等の液状化粧料に通常用いられる方法に従って製造することができる。具体的には、水溶性成分を水に溶解して水相とし、油分等の水不溶性成分を両親媒性成分(界面活性剤)と混合し、それを水相に添加して攪拌することにより調製される。
下記の表1~表4に示す処方で液状化粧料(化粧水)を調製し、それらの特性を下記の評価方法、評価基準に従って評価した。それらの結果を表に併せて示す。
「使用性の評価方法」
実施例及び比較例の各サンプルを、10名の専門パネルに実際に使用してもらい、使用性(べたつきのなさ、及びやわらかさ)について評価した。下記評価点基準に従って各パネルに5段階官能評価してもらい、その合計点により下記評価基準に基づいて判定した。
「評価点基準」
5:非常に優れている
4:優れている
3:普通
2:劣る
1:非常に劣る
「評価基準」
◎:合計点が40点以上
○:合計点が30~39点
△:合計点が20~29点
×:合計点が19点以下
各サンプルの安定性を以下の条件で評価した。
・60℃保管品の安定性:60℃に1週間保管後にL値の変動を評価。
・50℃保管品の安定性:50℃に2ヶ月間保管後にL値の変動を評価。
・凍結・融解後の安定性:凍結後、室温にて融解して室温に戻った後にL値の変動を評価。
「評価基準」
○:L値の変動が±3未満
○△:L値の変動が±3以上かつ±4未満
△:L値の変動が±4以上かつ±10未満
×:L値の変動が±10以上
塩型薬剤(4-メトキシサリチル酸カリウム塩)を配合した下記表5に示す処方で液状化粧料を調製し、前記と同様の評価を行った。結果を表5に併記する。
配合成分 配合量(質量%)
エタノール 5
グリセリン 5
ジプロピレングリコール 7
ブチレングリコール 5
エリスリトール 1
キシリトール 1
PEG/PPG-17/4ジメチルエーテル 3
POE(30)フィトステロール 0.14
セスキオレイン酸ソルビタン 0.02
イソステアリルアルコール 0.3
α‐オレフィンオリゴマー 0.2
キサンタンガム 0.1
クエン酸 適量
クエン酸ナトリウム 適量
メタリン酸ナトリウム 適量
フェノキシエタノール 適量
香料 適量
イオン交換水 残余
配合成分 配合量(質量%)
グリセリン 10
ジプロピレングリコール 7
ブチレングリコール 5
POE(10)メチルグルコシド 2
エリスリトール 1
PEG-400 1
PEG/PPG-14/7ジメチルエーテル 1
ポリオキシエチレン硬化ヒマシ油(60EO) 0.16
ジイソステアリン酸ポリグリセリル-2 0.08
イソステアリルアルコール 0.3
ヒドロキシエチルセルロース 0.1
クエン酸 適量
クエン酸ナトリウム 適量
エデト酸2ナトリウム 適量
フェノキシエタノール 適量
香料 適量
イオン交換水 残余
配合成分 配合量(質量%)
エタノール 7
グリセリン 4
ジプロピレングリコール 5
ブチレングリコール 3
POE(10)メチルグルコシド 1
PEG-20 1
PEG/PPG-14/7ジメチルエーテル 1
ポリオキシエチレン硬化ヒマシ油(60EO) 0.16
ジイソステアリン酸ポリグリセリル-2 0.08
イソステアリルアルコール 0.18
イソステアリン酸 0.06
α‐オレフィンオリゴマー 0.06
グリチルリチン酸ジカリウム 0.1
酢酸トコフェロール 0.1
トラネキサム酸 2
オウゴンエキス 0.1
ジオウエキス 0.1
ユキノシタエキス 0.1
オドリコソウエキス 0.1
クエン酸 適量
クエン酸ナトリウム 適量
エデト酸3ナトリウム 適量
フェノキシエタノール 適量
香料 適量
イオン交換水 残余
配合成分 配合量(質量%)
エタノール 8
グリセリン 3
ジプロピレングリコール 5
ブチレングリコール 3
POE(10)メチルグルコシド 1
PEG-20 1
PEG/PPG-14/7ジメチルエーテル 1
ポリオキシエチレン硬化ヒマシ油(60EO) 0.16
ジイソステアリン酸ポリグリセリル-2 0.08
イソステアリルアルコール 0.18
イソステアリン酸 0.06
α‐オレフィンオリゴマー 0.06
グリチルリチン酸ジカリウム 0.1
アスコルビン酸グルコシド 2
塩酸アルギニン 0.1
水酸化カリウム 0.4
オウゴンエキス 0.1
ジオウエキス 0.1
ユキノシタエキス 0.1
オドリコソウエキス 0.1
クエン酸 適量
クエン酸ナトリウム 適量
エデト酸2ナトリウム 適量
パラベン 適量
香料 適量
イオン交換水 残余
Claims (5)
- (a)0.01~3質量%の油分と、
(b)ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレンフィトステロールから選択される親水性界面活性剤とを含有し、L値が60以上である透明から半透明の液状化粧料であって、
イソステアリルアルコールが前記(a)油分の60質量%以上を占めることを特徴とする化粧料。 - (c)ジイソステアリン酸ポリグリセリル、セスキイソステアリン酸ソルビタン、及びセスキオレイン酸ソルビタンから選択される親油性界面活性剤を更に含有することを特徴とする、請求項1に記載の化粧料。
- 前記(b)親水性界面活性剤の配合量が0.01~3質量%であることを特徴とする、請求項1又は2に記載の化粧料。
- 前記(c)親油性界面活性剤の配合量が0.01~2質量%であることを特徴とする、請求項2又は3に記載の化粧料。
- (d)塩型薬剤を更に含有することを特徴とする、請求項1から4のいずれか一項に記載の化粧料。
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201280044322.5A CN103781462B (zh) | 2011-09-14 | 2012-08-14 | 液态化妆品 |
| HK14110793.2A HK1197188B (en) | 2011-09-14 | 2012-08-14 | Liquid cosmetic material |
| KR1020147009535A KR101589476B1 (ko) | 2011-09-14 | 2012-08-14 | 액상 화장료 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011-200427 | 2011-09-14 | ||
| JP2011200427A JP5753466B2 (ja) | 2011-09-14 | 2011-09-14 | 液状化粧料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2013038861A1 true WO2013038861A1 (ja) | 2013-03-21 |
Family
ID=47883096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2012/070673 Ceased WO2013038861A1 (ja) | 2011-09-14 | 2012-08-14 | 液状化粧料 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5753466B2 (ja) |
| KR (1) | KR101589476B1 (ja) |
| CN (1) | CN103781462B (ja) |
| TW (1) | TWI530298B (ja) |
| WO (1) | WO2013038861A1 (ja) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016013507A (ja) * | 2014-07-01 | 2016-01-28 | 株式会社タイホーコーザイ | 水中油型エマルション消泡剤組成物 |
| JP2023523014A (ja) * | 2020-04-23 | 2023-06-01 | アーチ・ユーケイ・バイオサイズ・リミテッド | ポリグリセロールエステルを有する相乗的な防腐性/パーソナルケア組成物 |
| WO2024014311A1 (en) * | 2022-07-12 | 2024-01-18 | L'oreal | Cosmetic composition comprising selected oil and diol |
| FR3138871A1 (fr) * | 2022-08-18 | 2024-02-23 | L'oreal | Composition comprenant huile et diol sélectionnés |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6629035B2 (ja) * | 2015-10-15 | 2020-01-15 | 日本メナード化粧品株式会社 | 液状油性口唇化粧料 |
| KR102598477B1 (ko) | 2016-09-21 | 2023-11-06 | (주)아모레퍼시픽 | 수중유형 화장료 조성물 |
| KR101904155B1 (ko) | 2018-06-01 | 2018-10-05 | 주식회사 엘지생활건강 | 고온 안정성이 우수한 나노 에멀전 조성물 |
| JP7162544B2 (ja) * | 2019-01-29 | 2022-10-28 | 株式会社 資生堂 | 白濁化粧料 |
| JP7550451B2 (ja) * | 2021-04-13 | 2024-09-13 | 株式会社みらい中央研究所 | 光彩を有する半透明化粧料 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005255667A (ja) * | 2004-02-12 | 2005-09-22 | Shiseido Co Ltd | 液状化粧料 |
| JP2009051810A (ja) * | 2007-07-27 | 2009-03-12 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
| JP2010173999A (ja) * | 2009-02-02 | 2010-08-12 | Shiseido Co Ltd | 液状化粧料 |
| JP2011136934A (ja) * | 2009-12-28 | 2011-07-14 | Shiseido Co Ltd | 化粧料 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04160264A (ja) | 1990-10-23 | 1992-06-03 | Seiko Epson Corp | アナログ時計用小型歯車 |
| JP2010120857A (ja) | 2008-11-17 | 2010-06-03 | Doctor Program Kk | 皮膚外用剤 |
-
2011
- 2011-09-14 JP JP2011200427A patent/JP5753466B2/ja active Active
-
2012
- 2012-08-14 CN CN201280044322.5A patent/CN103781462B/zh active Active
- 2012-08-14 WO PCT/JP2012/070673 patent/WO2013038861A1/ja not_active Ceased
- 2012-08-14 KR KR1020147009535A patent/KR101589476B1/ko not_active Expired - Fee Related
- 2012-09-11 TW TW101133182A patent/TWI530298B/zh not_active IP Right Cessation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005255667A (ja) * | 2004-02-12 | 2005-09-22 | Shiseido Co Ltd | 液状化粧料 |
| JP2009051810A (ja) * | 2007-07-27 | 2009-03-12 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
| JP2010173999A (ja) * | 2009-02-02 | 2010-08-12 | Shiseido Co Ltd | 液状化粧料 |
| JP2011136934A (ja) * | 2009-12-28 | 2011-07-14 | Shiseido Co Ltd | 化粧料 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016013507A (ja) * | 2014-07-01 | 2016-01-28 | 株式会社タイホーコーザイ | 水中油型エマルション消泡剤組成物 |
| JP2023523014A (ja) * | 2020-04-23 | 2023-06-01 | アーチ・ユーケイ・バイオサイズ・リミテッド | ポリグリセロールエステルを有する相乗的な防腐性/パーソナルケア組成物 |
| WO2024014311A1 (en) * | 2022-07-12 | 2024-01-18 | L'oreal | Cosmetic composition comprising selected oil and diol |
| FR3138871A1 (fr) * | 2022-08-18 | 2024-02-23 | L'oreal | Composition comprenant huile et diol sélectionnés |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103781462A (zh) | 2014-05-07 |
| TWI530298B (zh) | 2016-04-21 |
| KR101589476B1 (ko) | 2016-01-28 |
| JP2013060398A (ja) | 2013-04-04 |
| HK1197188A1 (zh) | 2015-01-09 |
| KR20140069134A (ko) | 2014-06-09 |
| TW201317008A (zh) | 2013-05-01 |
| JP5753466B2 (ja) | 2015-07-22 |
| CN103781462B (zh) | 2016-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5753466B2 (ja) | 液状化粧料 | |
| JP6010418B2 (ja) | 乳化組成物 | |
| JP3664734B2 (ja) | 水中油型乳化組成物及び水中油型乳化剤 | |
| KR102685043B1 (ko) | α겔 형성용 조성물, 및 이를 이용한 피부 외용 조성물 및 α겔 조성물 | |
| KR102359729B1 (ko) | 유화 제형의 끈적임 저감 및 투명도 향상용 화장료 조성물 | |
| WO2010086948A1 (ja) | 液状化粧料 | |
| TWI516278B (zh) | 油中水型乳化化妝料 | |
| AU2015389700A1 (en) | Cosmetic composition using plant-derived natural surfactant | |
| JP4160264B2 (ja) | 半透明または透明な化粧料 | |
| TWI225405B (en) | Oil-in-water emulsion composition | |
| JP2006282632A (ja) | 固形状油中水型乳化化粧料 | |
| WO2018212223A1 (ja) | 水中油型乳化組成物 | |
| CN100469347C (zh) | 液状化妆品 | |
| JP2006290762A (ja) | 水中油型乳化組成物 | |
| US10898426B2 (en) | Alpha-gel formation composition, external skin care composition using alpha-gel formation composition, and alpha-gel composition using alpha-gel formation composition | |
| JP2004307414A (ja) | W/o/wエマルション皮膚外用組成物およびその製造方法 | |
| JP2024095622A (ja) | 乳化粒子の微細化剤、乳化安定性向上剤、乳化物の乳化安定性を向上させる方法、乳化物の製造方法および乳化物 | |
| JP7778337B2 (ja) | 水中油滴型乳化物 | |
| JP3829049B2 (ja) | 水中油型乳化組成物 | |
| JP2008303164A (ja) | 油中水型固型メーキャップ化粧料 | |
| JP2001039851A (ja) | 目元用マッサージ化粧料 | |
| JP7278553B2 (ja) | ルテインのブルーライトカット能増強剤および、化粧品組成物 | |
| JP2013129625A (ja) | 油中水型乳化剤形の皮膚外用剤 | |
| WO2025028258A1 (ja) | ナイアシンアミドを含む化粧料 | |
| JP2010132620A (ja) | 油中水型乳化化粧料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 201280044322.5 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12832238 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 20147009535 Country of ref document: KR Kind code of ref document: A |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12832238 Country of ref document: EP Kind code of ref document: A1 |